Cardiol Therapeutics (TSX:CRDL): The clinical-stage life sciences company that’s developing CBD-based treatments for cardiovascular diseases
It can be hard to wrap your head around the number of diseases and conditions people live with every day, but almost everyone knows someone who is affected by heart disease. Around 73,000 people in the U.S. live with acute myocarditis, and approximately 38,000 live with recurrent pericarditis. Still, several intriguing medical plays are advancing unique treatments, and one among those that is clearly ahead of the pack.
The Market Herald Canada’s Jon Brown reports on a company making a real difference in combating this sometimes-lethal heart condition.
Weekly Update – Top Cannabis News Stories
1 | Top Story: HEXO (TSX:HEXO) and Tilray (TSX:TLRY) complete transaction, building an alliance between two cannabis giants.
2 | High Tide Inc. (TSXV:HITI) opens first Canna Cabana location in British Columbia.
3 | Terranueva Corp. (CSE :TEQ) closes $2.9 million private placement.
4 | MediPharm Labs Corp. (TSX:LABS) sells Australian subsidiary.
5 | Fire & Flower Holdings Corp. (TSX:FAF) and Pineapple Express launch recreational cannabis delivery in B.C.
Top Cannabis Stocks July 7 to July 13, 2022
1. T.WEED | 15,764 views | Canopy Growth Corp.
2. T.HEXO |11,886 views | HEXO Corp.
3. TLRY | 7,271 views | Tilray Brands Inc.
4. C.TNY | 3,867 views | Tinley Beverage Co Inc.
5. T.TBP | 3,444 views | Tetra Bio-Pharma Inc.
6. C.OILS | 2,563 views | Nextleaf Solutions Ltd .